CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
2.945 |
Evidence |
|
PLG |
PLG: Plasminogen precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
2.945 |
Evidence |
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
2.945 |
Evidence |
|
CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
2.945 |
Evidence |
|
SORBS3 |
SORBS3, SCAM1: Vinexin |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
2.945 |
Evidence |
|
HSP90AA1 |
Hsp89-alpha-delta-N |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
2.945 |
Evidence |
O
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
CDK6 |
CDK6: Cell division protein kinase 6 |
2.945 |
Evidence |
|
EGF |
EGF: Pro-epidermal growth factor precursor |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
2.945 |
Evidence |
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
2.945 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
KEL |
KEL: Kell blood group glycoprotein |
2.945 |
Evidence |
|
LYPD3 |
LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
2.945 |
Evidence |
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
MICAL-L1 |
MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 |
2.945 |
Evidence |
|
CGA |
CGA: Glycoprotein hormones alpha chain precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
2.945 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
2.945 |
Evidence |
|
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
2.945 |
Evidence |
|
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
HSP90AA1 |
Hsp89-alpha-delta-N |
2.945 |
Evidence |
|
LYPD3 |
LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
2.945 |
Evidence |
|
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
2.945 |
Evidence |
|
FSHB |
FSHB: Follitropin subunit beta precursor |
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
2.945 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
2.945 |
Evidence |
|
HD |
HD, IT15: Huntingtin |
ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
2.945 |
Evidence |
|
C8B |
C8B: Complement component C8 beta chain precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
2.945 |
Evidence |
|
LYPD3 |
LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
2.945 |
Evidence |
|
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
CDK6 |
CDK6: Cell division protein kinase 6 |
2.945 |
Evidence |
|
HSPA8 |
HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein |
NUP98 |
IPI00337397 |
2.942 |
Evidence |
|